Skip to main navigation

Who We Are
Our Portfolio
Pipeline
Media & Investors
- Media
- Investors
  - News Releases
  - Events
  - Financials
  - Governance
  - Stocks
  - Reports
  - Resources
Connect

We strive to put patients first and preserve their future possibilities

Investor Relations

Overview
News Releases
Events
Financials
Governance
Stock Info
Reports
Resources

Event Type Conference Presentation

Jun 13, 2024 11:00 AM EDT

UGN-102 12-Month Durability of Response Data Event

Listen to webcast

Upcoming events

There are no upcoming events available at this time.

Past events

Event Type Earnings Conference Call

Nov 6, 2024 10:00 AM EST

UroGen Pharma Q3 2024 Earnings Call

Listen to webcast

Event Type Conference Presentation

Sep 17, 2024 3:40 PM EDT

2024 Cantor Global Healthcare Conference

Listen to webcast

Event Type Conference Presentation

Sep 9, 2024 9:00 AM EDT

H.C. Wainwright 26th Annual Global Investment Conference

Listen to webcast

Event Type Earnings Conference Call

Aug 13, 2024 10:00 AM EDT

UroGen Pharma Q2 2024 Earnings Call

Listen to webcast

Event Type Conference Presentation

Jun 13, 2024 11:00 AM EDT

UGN-102 12-Month Durability of Response Data Event

Listen to webcast

Event Type Conference Presentation

May 28, 2024 3:30 PM EDT

TD Cowen Virtual Oncology Summit

Listen to webcast

Event Type Earnings Conference Call

May 13, 2024 10:00 AM EDT

UroGen Pharma Q1 2024 Earnings Call

Listen to webcast

Event Type Earnings Conference Call

Mar 14, 2024 10:00 AM EDT

UroGen Pharma Q4 2023 Earnings Call

Listen to webcast

Event Type Conference Presentation

Mar 4, 2024 1:30 PM EST

TD Cowen 44th Annual Health Care Conference

Listen to webcast

Event Type Conference Presentation

Feb 13, 2024 12:00 PM EST

Oppenheimer 34th Annual Healthcare Life Sciences Conference

Listen to webcast

Current page 1
Page 2
Page 3
…
Next
Last

Presentations

Urogen Corporate Presentation – November 2024

New Horizons in Bladder Cancer: UGN-102 Duration of Response Results from the ENVISION Study

New Horizons in Bladder Cancer: Insights from Top-Line Data of ATLAS & ENVISION Studies

Who We Are
Our Portfolio
Pipeline
Media
Investors

Privacy Policy
Patent Notice
Terms of Use
Funding Requests

Follow Us: Linkedin opens in new window Twitter opens in new window

Connect

JELMYTO^®, UroGen^®, and RTGel^® are registered trademarks of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.

US-UGN-00269 05/24